14-day Premium Trial Subscription Try For FreeTry Free
$0.0541
-0.0045 (-7.68%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Wednesday, 24th Apr 2024 BLPH stock ended at $0.0541. This is 7.68% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 17.21% from a day low at $0.0522 to a day high of $0.0612.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Oct 24, 2023 $0.0541 $0.0609 $0.0523 $0.0550 199 383
Oct 23, 2023 $0.0600 $0.0610 $0.0540 $0.0560 204 206
Oct 20, 2023 $0.303 $0.303 $0.0523 $0.0610 43 351
Oct 19, 2023 $0.303 $0.303 $0.0505 $0.0695 403 881
Oct 18, 2023 $0.303 $0.303 $0.0520 $0.0583 466 275
Oct 17, 2023 $0.303 $0.303 $0.0520 $0.0560 952 887
Oct 16, 2023 $0.303 $0.303 $0.0505 $0.0650 2 364 494
Oct 13, 2023 $0.303 $0.303 $0.0760 $0.103 13 116 059
Oct 12, 2023 $0.384 $0.405 $0.370 $0.385 42 072
Oct 11, 2023 $0.407 $0.407 $0.375 $0.375 20 695
Oct 10, 2023 $0.354 $0.377 $0.354 $0.366 18 438
Oct 09, 2023 $0.380 $0.382 $0.370 $0.377 5 792
Oct 06, 2023 $0.355 $0.381 $0.355 $0.380 20 528
Oct 05, 2023 $0.365 $0.383 $0.362 $0.362 47 053
Oct 04, 2023 $0.364 $0.384 $0.364 $0.366 54 543
Oct 03, 2023 $0.386 $0.409 $0.370 $0.386 23 825
Oct 02, 2023 $0.376 $0.401 $0.380 $0.394 21 607
Sep 29, 2023 $0.400 $0.400 $0.380 $0.398 22 067
Sep 28, 2023 $0.375 $0.401 $0.375 $0.381 19 890
Sep 27, 2023 $0.385 $0.404 $0.370 $0.375 160 425
Sep 26, 2023 $0.395 $0.412 $0.392 $0.400 37 614
Sep 25, 2023 $0.408 $0.420 $0.392 $0.403 25 795
Sep 22, 2023 $0.420 $0.420 $0.407 $0.408 8 833
Sep 21, 2023 $0.425 $0.425 $0.404 $0.412 61 343
Sep 20, 2023 $0.404 $0.453 $0.391 $0.438 167 107
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT